Evaluation of the Efficacy and Safety of Switching to Tenofovir, Emtricitabine, and Rilpivirine in Treatment-Experienced Patients

被引：5

作者：

Surgers, Laure ^{[1
,2
]}

Valin, Nadia ^{[1
]}

Viala, Celine ^{[3
]}

Boyd, Anders ^{[4
]}

Fonquernie, Laurent ^{[1
]}

Girard, Pierre-Marie ^{[1
,2
,4
]}

Morand-Joubert, Laurence ^{[2
,3
,4
]}

Meynard, Jean-Luc ^{[1
]}

机构：

[1] Hop St Antoine, AP HP, Serv Malad Infect & Trop, F-75571 Paris, France

[2] Univ Paris 06, Paris, France

[3] Hop St Antoine, AP HP, Unite Virol, F-75571 Paris, France

[4] INSERM, UMR S 1136, Inst Pierre Louis Epidemiol & Sante Publ, Paris, France

来源：

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2015年 / 68卷 / 01期

关键词：

HIV-1-INFECTED PATIENTS; DISOPROXIL FUMARATE; VIROLOGICAL FAILURE; EFAVIRENZ; TRIAL; THERAPY; PHASE-3;

D O I：

10.1097/QAI.0000000000000401

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：E10 / E12

页数：4

共 8 条

[1] Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial [J].

Cohen, Calvin J. ;

Andrade-Villanueva, Jaime ;

Clotet, Bonaventura ;

Fourie, Jan ;

Johnson, Margaret A. ;

Ruxrungtham, Kiat ;

Wu, Hao ;

Zorrilla, Carmen ;

Crauwels, Herta ;

Rimsky, Laurence T. ;

Vanveggel, Simon ;

Boven, Katia .

LANCET, 2011, 378 (9787) :229-237

[2] Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials [J].

Eron, Joseph J. ;

Young, Benjamin ;

Cooper, David A. ;

Youle, Michael ;

DeJesus, Edwin ;

Andrade-Villanueva, Jaime ;

Workman, Cassy ;

Zajdenverg, Roberto ;

Faetkenheuer, Gerd ;

Berger, Daniel S. ;

Kumar, Princy N. ;

Rodgers, Anthony J. ;

Shaughnessy, Melissa A. ;

Walker, Monica L. ;

Barnard, Richard J. O. ;

Miller, Michael D. ;

DiNubile, Mark J. ;

Nguyen, Bach-Yen ;

Leavitt, Randi ;

Xu, Xia ;

Sklar, Peter .

LANCET, 2010, 375 (9712) :396-407

[3] Factors Associated With Virological Failure in HIV-1-Infected Patients Receiving Darunavir/Ritonavir Monotherapy [J].

Lambert-Niclot, Sidonie ;

Flandre, Philippe ;

Valantin, Marc-Antoine ;

Peytavin, Gilles ;

Duvivier, Claudine ;

Haim-Boukobza, Stephanie ;

Algarte-Genin, Michele ;

Yazdanpanah, Yazdan ;

Girard, Pierre-Marie ;

Katlama, Christine ;

Calvez, Vincent ;

Marcelin, Anne-Genevieve .

JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (08) :1211-1216

[4] Ultrasensitive Assessment of Residual Low-Level HIV Viremia in HAART-Treated Patients and Risk of Virological Failure [J].

Maggiolo, Franco ;

Callegaro, Annapaola ;

Cologni, Giuliana ;

Bernardini, Claudia ;

Velenti, Daniela ;

Gregis, Giampietro ;

Quinzan, Giampaolo ;

Soavi, Laura ;

Iannotti, Nathalie ;

Malfatto, Emanuele ;

Leone, Sebastiano .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 60 (05) :473-482

[5] Efficacy and Safety 48 Weeks after Switching from Efavirenz to Rilpivirine Using Emtricitabine/Tenofovir Disoproxil Fumarate-Based Single-Tablet Regimens [J].

Mills, Anthony M. ;

Cohen, Calvin ;

DeJesus, Edwin ;

Brinson, Cynthia ;

Williams, Scott ;

Yale, Kitty L. ;

Ramanathan, Srini ;

Wang, Maggie H. ;

White, Kirsten ;

Chuck, Susan K. ;

Cheng, Andrew K. .

HIV CLINICAL TRIALS, 2013, 14 (05) :216-223

[6] Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial [J].

Molina, Jean-Michel ;

Cahn, Pedro ;

Grinsztejn, Beatriz ;

Lazzarin, Adriano ;

Mills, Anthony ;

Saag, Michael ;

Supparatpinyo, Khuanchai ;

Walmsley, Sharon ;

Crauwels, Herta ;

Rimsky, Laurence T. ;

Vanveggel, Simon ;

Boven, Katia .

LANCET, 2011, 378 (9787) :238-246

[7] Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants [J].

Palella, Frank J., Jr. ;

Fisher, Martin ;

Tebas, Pablo ;

Gazzard, Brian ;

Ruane, Peter ;

Van Lunzen, Jan ;

Shamblaw, David ;

Flamm, Jason ;

Ebrahimi, Ramin ;

Porter, Danielle ;

White, Kirsten ;

Hindman, Jason ;

Elbert, Elizabeth ;

De-Oertel, Shampa ;

Fralich, Todd .

AIDS, 2014, 28 (03) :335-344

[8] Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapy [J].

Rokx, C. ;

Verbon, A. ;

Rijnders, B. J. A. .

HIV MEDICINE, 2014, 15 (10) :611-614

← 1 →